Orchestra BioMed Holdings (OBIO) EPS (Basic) (2021 - 2026)
Orchestra BioMed Holdings (OBIO) posted quarterly EPS (Basic) of -$0.33 for Q1 2026, up 32.86% year-over-year from -$0.25 in Q1 2025, and down 345.96% quarter-over-quarter from $0.13 in Q4 2025.
Powered by 
Analysis
Orchestra BioMed Holdings (OBIO) EPS (Basic) (2021 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has reported EPS (Basic) for 6 consecutive years, with -$0.33 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 32.86% year-over-year to -$0.33; the TTM figure through Mar 2026 stood at -$0.9 (up 55.75% YoY), while the FY2025 annual figure was -$1.11, up 33.08% from the prior year.
- EPS (Basic) eased to -$0.33 in Q1 2026 per OBIO's latest filing, from $0.13 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.13 in Q4 2025 and bottomed at -$0.76 in Q3 2022.
- Historically, EPS (Basic) has averaged -$0.45 across 5 years, with a median of -$0.44 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Basic) tumbled 12418.95% — and 2025, when it jumped 130.63%.
- Orchestra BioMed Holdings' EPS (Basic) stood at -$0.61 in 2022, then soared by 38.83% to -$0.38 in 2023, then dropped by 16.38% to -$0.44 in 2024, then jumped by 130.63% to $0.13 in 2025, then slumped by 345.96% to -$0.33 in 2026.
- Business Quant data shows OBIO's EPS (Basic) at -$0.33 in Q1 2026, $0.13 in Q4 2025, and -$0.39 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Orchestra BioMed Holdings | 322.25 Mn | 127.72 Mn | 63,000.00 | -0.38 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.38 |
| Mar 31, 2026 | -0.33 |
| Dec 31, 2025 | 0.13 |
| Sep 30, 2025 | -0.40 |
| Jun 30, 2025 | -0.50 |
| Mar 31, 2025 | -0.49 |
| Dec 31, 2024 | -0.44 |
| Sep 30, 2024 | -0.41 |
| Jun 30, 2024 | -0.45 |
| Mar 31, 2024 | -0.37 |
| Dec 31, 2023 | -0.34 |
| Sep 30, 2023 | -0.39 |
| Jun 30, 2023 | -0.37 |
| Mar 31, 2023 | -0.42 |
| Dec 31, 2022 | -0.60 |
| Sep 30, 2022 | -0.73 |
| Jun 30, 2022 | -0.37 |
| Mar 31, 2022 | -0.25 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |